Simple research view

BIIB · Biogen Inc.

$252.26 +0.63% Oct 26 close

Detected setup Pocket Pivot · Setup Score 90/100

Stand aside — setup invalidated

Setup score 90, but distribution days reach 5 or more — stand aside until the condition resets.

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about BIIB

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$BIIB

Biogen Inc.

Biogen Inc. is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $37B.

Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 3+

$252.26 latest close

⚠ Risk Signals

Bearish MACD Divergence Price higher high ($224.51→$228.69) but MACD lower high (4.16→3.65) — momentum diverging

Bearish structure on the daily chart — a heads-up for anyone holding, not a short signal. Does not affect the bullish setup score.

Market Structure

Trend structure: uptrend

Latest event: structure_shift (bearish)

Support 192.27–193.20 · 4 touches · moderate

Support 184.90–186.02 · 4 touches · moderate

Support 198.72–200.29 · 4 touches · moderate

Support 168.56–169.24 · 3 touches · moderate

Support 180.33–181.77 · 3 touches · moderate

Join to Watchlist $BIIB Share card

Verdict · setup score 90/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 90, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart

Recent price action · daily

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

Minervini 2. ROE ≥ 17% — ROE 7.5%
Minervini 2. Revenue growth ≥ 20% YoY — +2.2% YoY
O'Neil A: Annual earnings & revenue quality — Rev +2.2% | ROE 7.5%
O'Neil M: Market in confirmed uptrend — Market phase: uptrend_under_pressure
Weinstein Volume expansion above average — Volume ratio 0.92x
Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base

Minority view — the council disagrees here

Minervini: watch Trend-template read: 10/12 pass; wait for the soft misses to improve.
O'Neil: watch CANSLIM read: 4/8 pass; improvement is still needed.
Weinstein: watch Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

71 Strong

Legend Score · rates the stock Strong (71/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

Relative Strength (25%) 93
Trend Template (25%) 100
Institutional Footprint (20%) 56
EPS Growth (15%) 31
Quality (SMR-like) (15%) 44

RS rank 92: top 8% of all stocks — true leadership. Trend template 8/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 56: neutral — no clear institutional conviction. EPS up +1% — growing, but below the 25% leadership bar. Quality 44: weak fundamentals (sales growth 30, return on equity 40, leverage 100). Updated 2026-10-27.

Earnings

Pre-earnings setup

Next earnings Wednesday, October 28, 2026 Before market open Exact clock time not supplied by source

Ordinary position sizing suppressed. Earnings are less than three full trading sessions away; treat the gap as event risk, not ordinary stop-distance risk.

Deterministic evidence

BIIB+0.63%

Sector proxy · XLV+0.00%

Broad market · SPY+0.71%

Same completed session window ending 2026-10-26. BIIB was +0.63 points vs XLV. -0.08 points vs SPY.

CatalystPending Stock reactionPositive Sector reactionWeak Opening surgePending Event riskEarnings-driven

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close+0.63% From the open+0.49% Range position59% GapNo gap

QQQ confirmationConfirming (+1.11%) SMH confirmationConfirming (+2.74%)

Short-term conviction -1 points.

A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $252.26 +0.6% Oct 26 close

52W High $254.41 0.8% below high

Wks Since High 0w

Base Depth 5.7%

RS Rank 82 percentile of scan

SMA 50 $224.23

Avg Vol 1,037,058

Rel Vol (Oct 26) 0.92× 0.69× on up days

More stats

52W Low $138.00

Tight Wks 0

Base B3

SMA 200 $199.78

RS Line vs High -0.8%

RS Line Slope +10.9% ▲

Group Rank #12/66

ADR% 2.7%

ATR(14) $7.45 (3.0%)

Vol Pace (live) N/A

A/D Days 13A / 10D

A/D Rating A

VDU Bars 0/10 d

Power Trend 12d

Earnings tomorrow

Position in 52-week range 98thpercentile of the 52-week range

$138.00low

$254.41high

BIIB Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for BIIB.

Create Free Account

Technical Analysis Report Card

$BIIB · $252.26 · as of 2026-10-26 · multi-factor read

/ 100

Technicals 98/100

Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend

Weekly ▲ Uptrend

Monthly ▲ Uptrend

Moving Averages

50-day$224.23 ↑

100-day$213.78 ↑

200-day$199.78 ↑

Bullish (50 > 200)

RSI (14)

Reading71.5 · Overbought

Overbought — buyers extended; watch for a pause or pullback.

MACD (12/26/9)

StateBullish

Histogram+2.321

Bullish — MACD above its signal line and above zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width96% · 18.7%

Near the upper band — buyers in control.

Volume · Buyer vs Seller

Up/Down vol0.69 · Neutral

Rel volume0.92×

Pocket pivots · 10d3

5d vs 50d vol136%

Heavy vol up / down5 / 3

Balanced — up/down volume is roughly even; no clear hand. Recent volume is expanding versus its baseline.

Pocket pivot 2 sessions ago — up-day volume beat every down day of the prior 10 sessions.
5 heavy-volume up days vs 3 down in the last 20 sessions.

Support & Resistance

R · $254.4152-week high

Price · $252.26now

S · $215.73swing level

S · $208.93swing level

S · $201.00swing level

Fibonacci · Uptrend swing

23.6%$238.01

38.2%$227.86

50.0%$219.66

61.8%$211.45

78.6%$199.78

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for BIIB — plus the full 500+ symbol scanner and Ask-the-Legends chat.

Start your 7-day free trial →

Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRSI overbought

Want this read in a legend's voice? Ask a Legend about BIIB

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (90/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 8 of 9 legends are Watching — building, not yet a confirmed buy.

Minervini Watch B Trend-template read: 10/12 pass; wait for the soft misses to improve.

partialEnter on break of $252.26 pivot with stop at $241.08 (risk 4.4%). SEPA Grade B (5/7).

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $252.26, MA150 $204.95, MA200 $199.78

1.2 150-day MA > 200-day MAMA150 $204.95 vs MA200 $199.78

Failing evidence

2. ROE ≥ 17%ROE 7.5%

2. Revenue growth ≥ 20% YoY+2.2% YoY

10/12 checks

Method → Playbook → Ask →

O'Neil Watch D CANSLIM read: 4/8 pass; improvement is still needed.

mediumPocket Pivot still forming in a top industry group — ideal buy point at $252.26 on big volume. CANSLIM 79.

Passing evidence

C: Quarterly EPS acceleration ≥ 25%+79.4% QoQ

L: RS rank ≥ 80 (IBD leadership)RS rank 92

Failing evidence

A: Annual earnings & revenue qualityRev +2.2% | ROE 7.5%

M: Market in confirmed uptrendMarket phase: uptrend_under_pressure

4/8 checks

Method → Playbook → Ask →

Weinstein Watch C Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $252.26 vs MA200 $199.78

Failing evidence

Volume expansion above averageVolume ratio 0.92x

Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base

5/7 checks

Method → Playbook → Ask →

dennis Watch C Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.

Passing evidence

No breakdown below the 20-day channel20-day low $215.73

Volatility-unit sizing (1N ≈ 1% of equity)1N = $6.63 (2.63% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk

Failing evidence

S1: 20-day Donchian breakoutNot confirmed

S2: 55-day Donchian breakoutNot confirmed

5/7 checks

Method → Playbook → Ask →

zanger Avoid C Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.

Passing evidence

Not extended (≤5% above the breakout point)Measured as passing

Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $290.10-$302.71; trail the rest

Failing evidence

Named Zanger pattern onlyPocket Pivot is not one of Zanger's six

Breakout volume 1.5-2.0x averageData unavailable

4/6 checks

Method → Playbook → Ask →

zweig Watch B Zweig read: part of his screen passes but not all: Insider buying — wait for the full growth screen before treating this as a Zweig setup.

Passing evidence

EPS growth above the market (≥15% QoQ)+79.4% QoQ — Zweig wants growth above the S&P average

Reasonable price for the growth (P/E ≤ 35)Trailing P/E 22.8x — no PEG or forward P/E stored

Failing evidence

Insider buyingNo insider buying flagged

Monetary conditions: don't fight the FedFed series stored but too thin to read direction

5/8 checks

Method → Playbook → Ask →

Livermore Watch B Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence

Price$252.26

Relative strengthRS 92

Failing evidence

Volume vs average0.92x

Pivotal point cleared on expanding volumeNot confirmed

4/6 checks

Method → Playbook → Ask →

Darvas Watch B Box-theory read: constructive evidence is present, but volume vs average is unresolved.

mediumStock is at the top of its box — Darvas would wait for a decisive breakout on volume.

Passing evidence

Price$252.26

Relative strengthRS 92

Failing evidence

Volume vs average0.92x

Box top broken on heavy volumeNot confirmed

4/6 checks

Method → Playbook → Ask →

Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence

Price$252.26

Relative strengthRS 92

Failing evidence

Volume vs average0.92x

Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending

4/6 checks

Method → Playbook → Ask →

Base & Breakout

Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Base & Breakout Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +3 A

Minervini · Grade Card

Fundamentals & leadership quality — Minervini’s published criteria · 5/7 met

B 5/7 criteria

Separate score from the Minervini Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✓ EPS acceleration ≥25% QoQ +79%

✗ Revenue growth ≥20% YoY +2%

✓ Gross margin ≥30% 75%

✗ ROE ≥17% 8%

✓ RS rating ≥80 (leadership) 92

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -0.8%

Method Playbook

Trade it like Livermore EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

Livermore B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.

Pivot

Pro level

Published-method rule: Treat the resistance break as a pivotal point only while the primary trend and relative strength remain aligned.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Wait for price and volume to confirm the pivotal-point break; anticipation below the line is not confirmation.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Place the initial stop below the pivotal line or the reaction low that would prove the breakout false.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Raise protection beneath successive higher reaction lows as the trend advances; never move a protective line farther away.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit when price fails the pivotal line, breaks the latest meaningful reaction low, or shows abnormal reversal action.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Pocket Pivot Historical replay: +20% before −8% within 40 sessions: 17% (n=657) · source bars 2024-11-01–2026-10-26 · avg +0.8% per setup (+0.10R) ⚠ 3rd-stage base

90 setup score

RS Score 92

Trend template 8/8 ✓

CANSLIM 79.4* (B)

volume ratio: 1.53 near moving avg: ✓ upper close: ✓ shooting star: ✗ price past buy range: ✗ vol beats down: ✓ bars since signal: 2 signal close: 253.84 validation reason: valid pocket-pivot multi tf evaluated: ✓ multi tf reason: weekly trend template 8/8 confirmed + no fresh 13-week low

Why This Setup? D+W Confluence

Pocket Pivot · schematic

Record Volume ⚠ 3rd-stage base ⚠ Not actionable yet

55 setup score

RS Score 92

Trend template 8/8 ✓

CANSLIM 79.0* (B)

cadence: daily lookback bars: 260 detector version: record_volume/2026-09-27 record bar ago: 2 record volume: 2237991 volume multiple: 2.25 volume ratio: 2.251 rare tier: ✗ bars since bigger: 24 since date: 2026-09-18 callout text: Highest daily volume since 2026-09-18 up day: ✓ absorbed: ✓ low held: ✓ day gain pct: 5.5 depth pct: 5.5 day range pct: 6.0 geometry: {'record_bar': {'bar': 257, 'bars_ago': 2, 'price': 253.84, 'date': '2026-10-22'}, 'record_volume': 2237991, 'callout_text': 'Highest daily volume since 2026-09-18', 'arrow_target': {'bar': 257, 'bars_ago': 2, 'price': 253.84, 'date': '2026-10-22'}} confidence kind: heuristic_match findings: ['Highest daily volume since 2026-09-18: 2,237,991 shares (2.3x the trailing average)', 'Price action constructive — closed up on the day (record bar $240.61 -> $253.84, now $252.26)'] validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported

Why This Setup? D+W Confluence

Record Volume · schematic

Highest daily volume since 2026-09-18 — 2,237,991 shares (2.3x average), 2 bars ago, and price action is constructive (closed up on the day). Big volume with holding prices means institutions are involved. Research/educational only, not a buy/sell recommendation. | Strong trend (8/8) | Top RS (92) | High-confidence pattern (74%) | Power Trend | Stage 2 | Readiness 64/100 (early) | CANSLIM 79.0 (B) | ⚠ 3rd-stage base; Not actionable yet

Wyckoff SOS ⚠ Volatility widening into breakout ⚠ Extended past buy zone ⚠ 3rd-stage base ⚠ Not actionable yet

55 setup score

RS Score 92

Trend template 8/8 ✓

CANSLIM 76.8* (B)

range low: 189.78 range high: 215.873 range pct: 0.137 sos thrust: 0.176 sos vol ratio: 1.931 sos bars ago: 2 near lps: ✗ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported

Why This Setup? D+W Confluence

Wyckoff SOS · schematic

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

4/7 universals met

Clear of earnings — not met in 1 days — event risk
Not chasing (in range) — partly met Pivot distance unknown
Volume confirms — partly met 0.9× average — light
A relative-strength leader — met RS rank 82
Asymmetric reward — met Met — levels are a Pro detail
In a confirmed uptrend — met Stage 2 · Trend template 8/8
Risk is defined — met Met — levels are a Pro detail

Why these seven? → The Universal Edge

Minervini Trend Template

8/8 ✓

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $252.26 vs SMA150 $204.95 / SMA200 $199.78

SMA 150 above SMA 200 SMA150 $204.95 vs SMA200 $199.78

SMA 200 trending up Slope +5.57 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $224.23

Price above SMA 50 $252.26 vs SMA50 $224.23

30%+ above 52-week low +82.8% from $138.00

Within 25% of 52-week high -0.8% from $254.41

RS score above 70 RS 92

Fundamentals

52W Range

98%

Mkt Cap SEC

37.0B

EPS QoQ

+79%

Rev YoY

+2%

ROE

Gross Margin

75%

D/E

0.34

EPS TTM

$8.79

P/E TTM

28.7x

Float

147M

Insider

No Buy

Company

Company profile

Biogen Inc.

BIIB · NASDAQ · Health Technology · Pharmaceuticals: Major

O'Neil · Grade Card

CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market

B 79.4* CANSLIM * disqualified on M

C · Curr. EPS

100

A · Annual EPS

N · New Highs

100

S · Supply/Demand

L · Leader RS

I · Inst. Spons.

100

M · Market

Weekly Context

Multi-timeframe signals from weekly bars

W. Trend

8/8

W. RS

W. Support

$179.15

W. Resist

$254.41

W. Patterns

Cup & Handle

Weekly Structure

Trend Neutral

Tight Weeks 0

Confirmation Neutral

Scan History

20× streak

Oct 27

Pocket Pivot ✓ Gate

Oct 27

Pocket Pivot ✓ Gate

Oct 26

Pocket Pivot ✓ Gate

92 0.0%

Oct 26

Pocket Pivot ✓ Gate

91 0.0%

Oct 23

Pocket Pivot ✓ Gate

94 +0.6%

Latest News

Headlines for BIIB

Loading headlines…

Get the full picture on BIIB

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial